The more Americans who take Ozempic, the faster the US economy could grow, Goldman Sachs says
With the US obesity rate hovering at around 40%, tens of millions of Americans could take GLP-1 drugs over the next few years ...
Health stocks hit after Trump taps RFK Jr for top job
The news prompted a sell-off across the industry. In the US, shares in Pfizer sank more than 4% and Moderna about 7% while UK ...